Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
First Online: 12 September 2022
Competing interests
: O.S. holds intellectual property rights to JAK kinases, is a scientific advisory board member and co-founder of Ajax Therapeutics and has received speaking honoraria from Pfizer and Abbvie.
